{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T21:05:32Z","timestamp":1785272732180,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.anndiagpath.2025.152536","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:19:11Z","timestamp":1754435951000},"page":"152536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Do urinary bladder smooth muscle neoplasms show morphologic and immunophenotypic features of their uterine fumarate hydratase-deficient counterparts?"],"prefix":"10.1016","volume":"79","author":[{"given":"Haijuan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna A.","family":"Giannico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut","family":"Akgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Khani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence A.","family":"Galea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaleel I.","family":"Al-Obaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Falzarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Wobker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keegan Q.","family":"Barry-Holson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin J.","family":"McHenry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankur R.","family":"Sangoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2025.152536_bb0005","series-title":"Urinary and male genital tumours WHO classification of tumours","first-page":"421","article-title":"Leiomyoma","volume":"vol. 8","author":"Magi-Galluzzi","year":"2022"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152536_bb0010","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0302-2838(03)00416-0","article-title":"Malignant non-urothelial neoplasms of the urinary bladder: a review","volume":"44","author":"Dahm","year":"2003","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152536_bb0015","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/PAS.0b013e3181cf326d","article-title":"Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases","volume":"34","author":"Lee","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152536_bb0020","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00000478-200203000-00002","article-title":"Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma","volume":"26","author":"Martin","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152536_bb0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00000478-199406000-00001","article-title":"Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases","volume":"18","author":"Bell","year":"1994","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152536_bb0030","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PAS.0000000000002362","article-title":"Prospective fumarate hydratase tumor predisposition syndrome screening in patients with uterine smooth muscle tumors: age, morphology, fumarate hydratase\/S-(2-succino) cysteine immunohistochemistry, and germline testing","volume":"49","author":"McHenry","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152536_bb0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/PAS.0000000000001222","volume":"43","author":"Rabban","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.anndiagpath.2025.152536_bb0040","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.ajhg.2024.07.019","article-title":"Implementation of a dyadic nomenclature for monogenic diseases","volume":"111","author":"Thaxton","year":"2024","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.anndiagpath.2025.152536_bb0045","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/PAS.0000000000001293","article-title":"Detailed morphologic and immunohistochemical characterization of myomectomy and hysterectomy specimens from women with hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC)","volume":"43","author":"Chan","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152536_bb0050","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam Cancer"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152536_bb0055","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","article-title":"Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis","volume":"79","author":"Smit","year":"2011","journal-title":"Clin Genet"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152536_bb0060","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.anndiagpath.2025.152536_bb0065","series-title":"Urinary and male genital tumours WHO classification of tumours","first-page":"78","article-title":"Fumarate hydratase-deficient renal cell carcinoma","volume":"vol. 8","author":"Hes","year":"2022"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152536_bb0070","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/10668969221074600","article-title":"A clinicopathological and molecular analysis of fumarate hydratase (FH)-deficient renal cell carcinomas with heterogeneous loss of FH expression","volume":"30","author":"Anderson","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152536_bb0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.humpath.2022.12.013","article-title":"Characterization of protein S-(2-succino)-cysteine (2SC) succination as a biomarker for fumarate hydratase-deficient renal cell carcinoma","volume":"134","author":"Mannan","year":"2023","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152536_bb0080","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41379-018-0017-7","volume":"31","author":"Muller","year":"2018","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152536_bb0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/PAS.0000000000001372","article-title":"A clinicopathologic and molecular analysis of fumarate hydratase-deficient renal cell carcinoma in 32 patients","volume":"44","author":"Lau","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152536_bb0090","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","article-title":"Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer","volume":"177","author":"Grubb","year":"2007","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152536_bb0095","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.path.2018.07.010","article-title":"Recognizing hereditary renal cancers through the microscope: a pathology update","volume":"11","author":"Peng","year":"2018","journal-title":"Surg Pathol Clin"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152536_bb0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/PAS.0000000000000617","article-title":"Fumarate hydratase-deficient renal cell carcinoma is strongly correlated with fumarate hydratase mutation and hereditary leiomyomatosis and renal cell carcinoma syndrome","volume":"40","author":"Trpkov","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2025.152536_bb0105","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","article-title":"The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome","volume":"31","author":"Merino","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152536_bb0110","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry","volume":"38","author":"Chen","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2025.152536_bb0115","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.5858\/arpa.2018-0216-RA","article-title":"Hereditary leiomyomatosis and renal cell carcinoma syndrome (HLRCC): a contemporary review and practical discussion of the differential diagnosis for HLRCC-associated renal cell carcinoma","volume":"142","author":"Skala","year":"2018","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152536_bb0120","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/PGP.0000000000000797","article-title":"Fumarate hydratase deficiency should be considered in the differential diagnosis of uterine and extrauterine smooth muscle tumors of uncertain malignant potential (STUMP)","volume":"41","author":"Pors","year":"2022","journal-title":"Int J Gynecol Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152536_bb0125","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PGP.0000000000000918","article-title":"Fumarate hydratase and S-(2-succinyl)-cysteine immunohistochemistry shows evidence of fumarate hydratase deficiency in 2% of uterine leiomyosarcomas: a cohort study of 348 tumors","volume":"42","author":"Chapel","year":"2023","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152536_bb0130","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000000626","article-title":"Immunohistochemistry for 2-succinocysteine (2SC) and fumarate hydratase (FH) in cutaneous leiomyomas may aid in identification of patients with HLRCC (hereditary leiomyomatosis and renal cell carcinoma syndrome)","volume":"40","author":"Buelow","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.anndiagpath.2025.152536_bb0135","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/cup.12396","article-title":"Fumarate hydratase immunohistochemical staining may help to identify patients with multiple cutaneous and uterine leiomyomatosis (MCUL) and hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome","volume":"41","author":"Llamas-Velasco","year":"2014","journal-title":"J Cutan Pathol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152536_bb0140","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/01913128309141823","article-title":"Intracytoplasmic inclusion bodies in leiomyoma of the urinary bladder","volume":"5","author":"Alroy","year":"1983","journal-title":"Ultrastruct Pathol"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425001017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425001017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T01:12:30Z","timestamp":1755825150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913425001017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":28,"alternative-id":["S1092913425001017"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152536","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do urinary bladder smooth muscle neoplasms show morphologic and immunophenotypic features of their uterine fumarate hydratase-deficient counterparts?","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152536"}}